We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
-18.86%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$94.9M
AUM Growth
-$11.6B
(-99%)
Cap. Flow
+$352M
Cap. Flow
% of AUM
370.94%
Top 10 Holdings %
Top 10 Hldgs %
49.64%
Holding
849
New
169
Increased
282
Reduced
215
Closed
183
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Plains All American Pipeline
PAA
|
+$71.8M |
| 2 |
Blackstone
BX
|
+$60.2M |
| 3 |
EEP
Enbridge Energy Partners
EEP
|
+$60.1M |
| 4 |
Brookfield
BN
|
+$55.9M |
| 5 |
WPZ
Williams Partners L.P.
WPZ
|
+$53.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMLP
CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE)
CMLP
|
+$122M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$25.2M |
| 3 |
NE
Noble Corporation
NE
|
+$23.5M |
| 4 |
Transocean
RIG
|
+$22.7M |
| 5 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 67.78% |
| 2 | Healthcare | 2.32% |
| 3 | Materials | 2.09% |
| 4 | Financials | 1.64% |
| 5 | Consumer Discretionary | 1.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Regency Centers
REG
$15B
| $7.45K | 0.01% |
11,991
+200
| +2% | +$12.3K |
|
|
ARNA
227
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $7.24K | 0.01% |
37,885
+13,863
| +58% | +$471K |
|
228
Kilroy Realty
KRC
$4.58B
| $7.21K | 0.01% |
11,072
+200
| +2% | +$13.7K |
|
229
Alcoa
AA
$11.7B
| $7.16K | 0.01% |
30,821
+22,153
| +256% | +$519K |
|
|
AERI
230
DELISTED
Aerie Pharmaceuticals
AERI
| $7.13K | 0.01% |
40,215
+15,008
| +60% | +$272K |
|
231
Ardelyx
ARDX
$1.24B
| $7.01K | 0.01% |
40,558
+22,097
| +120% | +$412K |
|
|
NDRM
232
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $6.96K | 0.01% |
33,687
+16,814
| +100% | +$345K |
|
233
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
| $6.95K | 0.01% |
+8,178
| New | +$694K |
|
234
Valero Energy
VLO
$89.8B
| $6.85K | 0.01% |
11,391
-841
| -7% | -$53.4K |
|
|
OTIC
235
DELISTED
Otonomy, Inc.
OTIC
| $6.73K | 0.01% |
37,774
+13,855
| +58% | +$328K |
|
236
Archrock
AROC
$6.33B
| $6.65K | 0.01% |
36,958
-9,260
| -20% | -$222K |
|
237
Ascendis Pharma A/S
ASND
$16.7B
| $6.6K | 0.01% |
37,310
+13,684
| +58% | +$266K |
|
|
PGNX
238
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $6.24K | 0.01% |
109,075
+39,953
| +58% | +$307K |
|
239
SLB Ltd
SLB
$77.8B
| $6.16K | 0.01% |
8,935
+425
| +5% | +$33.6K |
|
240
PepsiCo
PEP
$186B
| $6.08K | 0.01% |
6,450
+384
| +6% | +$36.5K |
|
|
TVRD
241
Tvardi Therapeutics
TVRD
$23.5M
| $5.95K | 0.01% |
1,156
+528
| +84% | +$353K |
|
242
Starbucks
SBUX
$118B
| $5.92K | 0.01% |
10,418
-1,577
| -13% | -$88.4K |
|
243
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.11B
| $5.92K | 0.01% |
+11,948
| New | +$591K |
|
244
Public Service Enterprise Group
PEG
$39.8B
| $5.88K | 0.01% |
+13,956
| New | +$569K |
|
245
Karyopharm Therapeutics
KPTI
$168M
| $5.88K | 0.01% |
3,725
+1,363
| +58% | +$365K |
|
246
Coca-Cola Consolidated
COKE
$12.3B
| $5.88K | 0.01% |
+30,380
| New | +$495K |
|
247
Visa
V
$677B
| $5.85K | 0.01% |
8,404
-207
| -2% | -$14.8K |
|
248
Nike
NKE
$61.9B
| $5.84K | 0.01% |
9,492
-2,272
| -19% | -$129K |
|
249
T. Rowe Price
TROW
$25B
| $5.81K | 0.01% |
8,359
+1,491
| +22% | +$110K |
|
250
Avery Dennison
AVY
$12.3B
| $5.79K | 0.01% |
+10,238
| New | +$618K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, ALPS Advisors held 849 positions worth $94.9M, down 99% from $11.7B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
ALPS Advisors deployed $352M of net new capital in Q3 2015, opening 169 new positions and adding to 282 existing holdings. Its largest new stake was Brookfield: 4,795,507 shares worth $52.9K.
By sector, the portfolio is most concentrated in Energy at 68% of assets, down from 70% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Magellan Midstream Partners, L.P., an estimated $21.8M trimmed.
- ALPS Advisors's largest Q3 2015 buy was Brookfield: 4,795,507 shares worth $52.9K.
- ALPS Advisors added most to Plains All American Pipeline in Q3 2015, an estimated $71.8M increase.
- ALPS Advisors's biggest Q3 2015 reduction was Magellan Midstream Partners, L.P., cutting an estimated $21.8M.
- ALPS Advisors fully exited CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE) in Q3 2015, selling an estimated $122M.
- ALPS Advisors's ten largest holdings make up 50% of its $94.9M portfolio in Q3 2015.
- ALPS Advisors opened 169 new positions and closed 183 in Q3 2015.
- ALPS Advisors's portfolio value fell 99% quarter-over-quarter to $94.9M.
Based on ALPS Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.